Please wait
S-8 EX-FILING FEES 0001176309 N/A N/A 0001176309 1 2025-08-20 2025-08-20 0001176309 2025-08-20 2025-08-20 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-8

Oramed Pharmaceuticals Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common stock, par value $0.012 per share, to be issued under the Oramed Pharmaceuticals Inc. Amended and Restated 2019 Stock Incentive Plan, as amended   (1)   Other   2,000,000   $ 2.05   $ 4,100,000.00   0.0001531   $ 627.71
                                           
Total Offering Amounts:   $ 4,100,000.00         627.71
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 627.71

 

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, or the Securities Act, this registration statement also covers an indeterminate number of additional shares of common stock that may be issued under the Oramed Pharmaceuticals Inc. Amended and Restated 2019 Stock Incentive Plan, as amended, to prevent dilution resulting from a share split, reverse share split, stock dividend, combination or reclassification of the common stock, or any other increase or decrease in the number of issued shares of common stock effected without receipt of consideration by the registrant.

The amount registered represents common stock issuable upon issuance, vesting and/or exercise of awards granted under the Oramed Pharmaceuticals Inc. Amended and Restated 2019 Stock Incentive Plan, as amended from time to time.

The proposed maximum offering price per share is estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and (h) under the Securities Act, based upon the average of the high $2.12 and low $1.98 prices of the common stock, as reported on the as reported on the Nasdaq Capital Market on August 15, 2025.